Managing Your 'Top 5%': What Capitated Wound Care Actually Costs for High-Risk Diabetic and Immobile Members

Why Standard Case Management Fails the 5% with Wounds

You have case managers. They're calling patients, coordinating referrals, reinforcing medication adherence. It works fine for the 95%.

But when that case manager picks up a diabetic patient with a worsening foot ulcer and mobility limitations, the standard playbook breaks down:

• The case manager can't assess the wound. They have no way to know if it's healing or deteriorating.
• The case manager can call the wound center and confirm the patient "has an appointment," but has no real-time visibility into adherence or clinical trajectory.
• The case manager can't coordinate vascular or infectious disease escalation because that requires clinical assessment they're not equipped to provide.
• The case manager can't address the root environmental problem: the patient's apartment lacks mobility equipment, their nutrition is inadequate, and their caregiver is overwhelmed.

Your case manager is trying to manage a clinical problem using a care coordination playbook. It doesn't work. The patient ends up in the ER or hospital anyway, and now you're in crisis mode instead of prevention mode.

This is when you realize: These patients need actual medical management, not just care management. They need clinical people in their home, weekly, with authority to escalate.

That's expensive to contract for visit-by-visit. It's cheap to contract for with capitation.

The High-Risk Wound Cohort

Let's define who we're talking about:

• Diabetic patients with active foot ulcers (any stage)
• Immobilized patients (mobility aids required for ADL) with Stage 3-4 pressure injuries
• Patients with both diabetic disease and immobility constraints
• Patients meeting criteria: age 60+, PMPM >$15,000, or known vascular disease history

These patients represent maybe 2-4% of a plan's membership. But they're driving outsized costs because their care is fragmented and crisis-reactive.

Typical annual cost for a high-risk diabetic with active wounds: $35,000-$60,000/year (absent aggressive management).

For comparison, your baseline diabetic member costs: $8,000-$12,000/year.

The Capitation Model

Here's how you stabilize the MLR: You cap the cost. You say to a specialized provider: "We have 40-60 patients with active wounds or high-risk diabetes. We'll pay you a fixed monthly capitation for unlimited wound care, coordination, and escalation management for these patients."

The rate depends on risk and acuity, but a typical range for high-risk wound patients is:

• Months 1-3 (active stabilization): $3,000 PMPM
• Months 4-9 (maintenance): $2,500 PMPM, or $450 PMPM if in remission/maintenance mode
• Full-risk provider groups (sub-capitation): $2,000 PMPM wholesale rate (plan keeps the spread)

What does that buy you?

• Weekly or bi-weekly home visits
• Real-time clinical assessment and wound trajectory tracking
• Coordination across specialists (vascular, podiatry, nutrition, ID)
• Escalation protocols for infection, rapid deterioration
• Integration of clinical data into your population health dashboards
• Authorization to manage the patient's wound care trajectory independently

The Math

Let's work through a cohort example:

You identify 50 high-risk patients with active wounds or high-risk diabetes requiring wound management.

• Months 1-3: 50 patients × $3,000 PMPM × 3 months = $450,000
• Months 4-9: Assume 30 patients remain active (others in remission): 30 × $2,500 PMPM × 6 months = $450,000
• Months 10-12: Assume 15 patients in maintenance: 15 × $450 PMPM × 3 months = $20,250

Total annual capitated cost: $920,250 for 50 patients = $18,405 per patient per year.

What's the alternative cost (fee-for-service management without specialization)?

• Wound center visits (1x/week, 52 weeks): 52 × $350 = $18,200
• ER visits due to inadequate outpatient management (average 2/year): 2 × $2,500 = $5,000
• Hospitalization for wound infection or complication (average 1 per 5 patients over year): $25,000 × 0.2 = $5,000
• Specialty consults (vascular, ID) lacking coordinated timing: $3,000
• Average amputation cost spread across cohort (if 5% amputation rate): $125,000 × 0.05 = $6,250

Total fee-for-service cost: $37,450 per patient per year.

Capitated cost: $18,405. Fee-for-service cost: $37,450. Savings: $19,045 per patient, or 49% reduction in cost.

With 50 patients, that's $952,250 in annual savings.

And that's before accounting for quality metrics, readmission reduction, and the stability of having a predictable cost structure instead of random amputation claims blowing up your Q3 results.

Why This Matters for Your Risk-Based Contracts

If you're operating under shared savings or full-risk capitation, this becomes non-negotiable.

A 5% amputation rate in your high-risk wound cohort is a $6,250 cost-per-patient head-wind on your shared savings target. It directly reduces your profitability.

A 2% amputation rate cuts that to $2,500. A 1% rate (which is achievable with aggressive early intervention) is $1,250.

The difference between a 5% amputation rate and a 1% amputation rate, across 50 patients, is $200,000 in annual margin improvement.

That's not theoretical. That's actuarial.

The Staffing and Scalability Question

Here's the structural question: How many FTE clinicians do you need to manage 50 high-risk wound patients with capitated home-based care?

In a traditional wound center model, you'd need a blended team of RNs, wound specialists, and administrative staff—probably 2-3 FTE per 50 patients, depending on visit frequency.

In a capitated home-based model with real-time clinical data and clear escalation triggers, you can do it with 1.5-2 FTE clinicians per 50 patients, because:

• You're not managing patients who don't need management (those in remission are monitored, not actively treated)
• Your escalation protocols are automated (real-time data flagging high-risk trajectories)
• You're preventing the complications that require additional clinical labor (infections, hospitalizations)

That's why capitation works better than FFS for specialized management. It incentivizes efficiency and prevention, not volume.

The Minimum Viable Population

You need critical mass to make this work. The minimum population for a wound care capitation pilot is:

• 3,000 lives with diabetes, OR
• 40-50 patients with active wounds or high-risk diabetic disease

Below that, you don't have enough volume to absorb the fixed cost of clinical staffing and coordination infrastructure. Above that, you scale efficiently with additional clinicians.

The Conversation Starter

This is the piece that should end with a clear next step: a conversation.

You don't need to overhaul your entire wound care strategy today. But if you're sitting on a 5% amputation rate in your highest-risk cohort, and your margin is being crushed by unpredictable surgical costs, it's worth asking one question:

"What if we capped the cost, guaranteed the outcomes, and measured healing in real time instead of waiting for claims data?"

That's the offer. That's the conversation. And that's why capitated wound care for your top 5% is the single best margin stabilizer available.